<!DOCTYPE HTML PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<HTML lang="pt-BR">
<HEAD>
<META http-equiv="Content-Type" content="text/html; charset=ISO-8859-1">
<link href="images/v2/fav_ico_lattes.ico" rel="Shortcut Icon">
<meta content="Sistema de Curr&iacute;culos Lattes 2.0 (CNPq)" http-equiv="generator">
<meta content="curr&iacute;culo,curriculo,curriculum,cv,vitae,lattes,produ&ccedil;&atilde;o,producao,cient&iacute;fica,cientifica,Brasil" http-equiv="keywords">
<TITLE>Curr&iacute;culo do Sistema de Curr&iacute;culos Lattes (Andre Tesainer Brunetto)</TITLE>
<link type="text/css" rel="stylesheet" href="css/import.css">
<link type="text/css" href="css/tablet-mobile.css" rel="stylesheet">
<link type="text/css" rel="stylesheet" href="css/jquery.megamenu.css">
<link type="text/css" rel="stylesheet" href="css/style_curiculo.css">
<link type="text/css" rel="stylesheet" href="css/v2/espelho.css">
<link type="text/css" rel="stylesheet" href="css/impressao.css">
<script type="text/javascript" src="js/v2/jquery.min.js"></script><script src="js/jquery.cookie.js" type="text/javascript"></script><script src="js/acessibilidade.js" type="text/javascript"></script><script type="text/javascript" src="js/v2/tooltip-position.js"></script><script type="text/javascript" src="js/v2/jquery.tipsy.js"></script><script type="text/javascript" src="js/v2/jquery.megamenu.js"></script><script type="text/javascript" src="js/v2/byOrder.js"></script><script type="text/javascript" src="js/v2/font-size.js"></script><script type="text/javascript" src="js/v2/cv_citacoes.js"></script><script type="text/javascript" src="js/v2/hint_ajax.js"></script><script type="text/javascript" src="js/v2/menuFlowScroll.js"></script><script type="text/javascript" src="js/v2/videoUtils.js"></script><script type="text/javascript">
			
			var menu = {
				iniciar: function(id) {
					jkmegamenu.definemenu("ancora-menu-" + id, "menu-" + id, "focus");
				}
			};
			
			function abreLinkHistoricoPublicacoes(codigo,nome){
            	var j = window.open("historicoAtualizacao.jsp?id="+codigo+"&nome="+nome+"&fromBusca=1", "historico","resizable=no,menubar=no,toolbar=no,status=yes,scrollbars=yes,width=550px,height=470px,left=0,top=0");
            	if(j){
            		j.focus();
            	} else {
            		alert('Por favor, desabilite o bloqueador de popups');
            	}
			}
			
			var autores = {
				exibir: function() {
					$(this).hide().parent().find(".autores-et-al").show();
				},
				ocultar: function() {
					$(this).parent().hide().parent().find(".autores-et-al-plus").show();
				}
			};
				
			$(document).ready(function(){
			
				$(".ajaxJCR").ajaxJCR();
				
				$(".ajaxCAPES").ajaxCAPES();
				
				$(".ajaxINPI").ajaxINPI();
				
				$("div.citacoes").verificarCitacoes();
				
				$(".tooltip").tipsy({gravity: 's'});
				
				$(".autores-et-al-plus").click(autores.exibir);
				
				$(".autores-et-al-minus").click(autores.ocultar);
        			
      		});			  
      		
      		                                
		
	</script><script type="text/javascript">
					
					  var _gaq = _gaq || [];
					  _gaq.push(['_setAccount', 'UA-35652740-1']);
					  _gaq.push(['_trackPageview']);
					
					  (function() {
					    var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true;
					    ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js';
					    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s);
					  })();
					
					</script>
</HEAD>
<BODY>
<div class="page min-width">
<div class="header">
<div class="header-content max-width">
<div class="identity center">
<div class="combo">
<h1 class="escondido"> Curr&iacute;culo Lattes - Busca Textual - Visualiza&ccedil;&atilde;o do Curr&iacute;culo </h1>
<a href="http://lattes.cnpq.br/" title="Curr&iacute;culo Lattes" target="_blank"><img title="Curr&iacute;culo Lattes" alt="Curr&iacute;culo Lattes" src="images/titulo-sistema.png"></a>
</div>
<div class="menu-header">
<span class="tituloFlow"></span><span class="linksFlow"><a href="http://buscatextual.cnpq.br/buscatextual/visualizacv.do?id=K4475230A2&amp;idiomaExibicao=2" class="btn-br">English</a><a title="Imprimir curr&iacute;culo" class="bt-menu-header titBottom  icons-top icons-top-print" href="javascript:window.print()"></a><a title="Aumentar a fonte" class="bt-menu-header titBottom fontMais icons-top icons-top-fontMais" href="javascript:void(0)"></a><a title="Fonte padr&atilde;o" class="bt-menu-header titBottom fontMenos icons-top icons-top-fontMenos" href="javascript:void(0)"></a><a title="Alto contraste" class="bt-menu-header titBottom contraste icons-top icons-top-contraste-en" href="javascript:void(0)"></a><a href="download.do?metodo=apresentar&amp;idcnpq=8913704029973970" target="_blank" class="bt-menu-header titBottom fontMenos icons-top icons-top-xml" title="Baixar Currículo em XML" /><a title="Ajuda" class="bt-menu-header titBottom icons-top icons-top-help" target="_blank" href="http://ajuda.cnpq.br/index.php"></a></span>
</div>
<div class="logo">
<a target="_blank" href="http://cnpq.br/">
<h2>CNPq - Conselho Nacional de Desenvolvimento Cient&iacute;fico e Tecnol&oacute;gico</h2>
</a>
</div>
</div>
</div>
</div>
<div class="navigation-wrapper">
<div class="center navigation-wrapper-line">
<div class="menuPrincipal">
<div class="menuCtl menuAcesso">
<div class="menucent"><script type='text/javascript'>menu.iniciar("dados-gerais");</script>
		
		
		<a id="ancora-menu-dados-gerais" href="javascript:void(0)" class="acessibilidade"><span></span>Dados gerais</a>
		
	
		
		
		<div id="menu-dados-gerais" class="megamenu">
		
		<div class='column'><h3></h3><ul>
		
		
		<li><a href="#Identificacao">Identificação</a></li>
		
	
		
		
		<li><a href="#Endereco">Endereço</a></li>
		
	
		
		
		<li><a href="#Idiomas">Idiomas</a></li>
		
	
		
		
		<li><a href="#PremiosTitulos">Prêmios e títulos</a></li>
		
	</ul></div>
		
		
		<div class="clear"></div></div>
		
	<script type='text/javascript'>menu.iniciar("formacao");</script>
		
		
		<a id="ancora-menu-formacao" href="javascript:void(0)" class="acessibilidade separador"><span></span>Formação</a>
		
	
		
		
		<div id="menu-formacao" class="megamenu">
		
		<div class='column'><h3></h3><ul>
		
		
		<li><a href="#FormacaoAcademicaTitulacao">Formação acadêmica/titulação</a></li>
		
	
		
		
		<li><a href="#FormacaoComplementar">Formação complementar</a></li>
		
	</ul></div>
		
		
		<div class="clear"></div></div>
		
	<script type='text/javascript'>menu.iniciar("atuacao");</script>
		
		
		<a id="ancora-menu-atuacao" href="javascript:void(0)" class="acessibilidade separador"><span></span>Atuação</a>
		
	
		
		
		<div id="menu-atuacao" class="megamenu">
		
		<div class='column'><h3></h3><ul>
		
		
		<li><a href="#AtuacaoProfissional">Atuação profissional</a></li>
		
	
		
		
		<li><a href="#LinhaPesquisa">Linhas de pesquisa</a></li>
		
	
		
		
		<li><a href="#RevisorPeriodico">Revisor de periódico</a></li>
		
	
		
		
		<li><a href="#AreasAtuacao">Áreas de atuação</a></li>
		
	</ul></div>
		
		
		<div class="clear"></div></div>
		
	<script type='text/javascript'>menu.iniciar("producoes");</script>
		
		
		<a id="ancora-menu-producoes" href="#ProducoesCientificas" class="acessibilidade separador"><span></span>Produções</a>
		
	
		
		
		<div id="menu-producoes" class="megamenu">
		
		<div class='column'><div class='subtitMenu'><a href='#ProducaoBibliografica'>Produção Bibliográfica</a></div><h3></h3><ul>
		
		
		<li><a href="#ArtigosCompletos">Artigos completos publicados em periódicos</a></li>
		
	
		
		
		<li><a href="#ArtigosAceitos">Artigos aceitos para publicação</a></li>
		
	
		
		
		<li><a href="#LivrosCapitulos">Livros e capítulos</a></li>
		
	
		
		
		<li><a href="#TextosJornaisRevistas">Textos em jornais ou revistas (magazine)</a></li>
		
	
		
		
		<li><a href="#TrabalhosPublicadosAnaisCongresso">Trabalhos publicados em anais de congressos</a></li>
		
	
		
		
		<li><a href="#ApresentacaoTrabalho">Apresentações de trabalho</a></li>
		
	
		
		
		<li><a href="#OutrasProducoesBibliograficas">Partitura musical</a></li>
		
	
		
		
		<li><a href="#OutrasProducoesBibliograficas">Tradução</a></li>
		
	
		
		
		<li><a href="#OutrasProducoesBibliograficas">Prefácio, pósfacio</a></li>
		
	
		
		
		<li><a href="#OutrasProducoesBibliograficas">Outras produções bibliográficas</a></li>
		
	</ul></div><div class='column'><div class='subtitMenu'><a href='#ProducaoTecnica'>Produção Técnica</a></div><h3></h3><ul>
		
		
		<li><a href="#AssessoriaConsultoria">Assessoria e consultoria</a></li>
		
	
		
		
		<li><a href="#SoftwareSemPatente">Programas de computador sem registro</a></li>
		
	
		
		
		<li><a href="#ProdutosTecnologicos">Produtos tecnológicos</a></li>
		
	
		
		
		<li><a href="#ProcessosTecnicas">Processos e técnicas</a></li>
		
	
		
		
		<li><a href="#TrabalhosTecnicos">Trabalhos técnicos</a></li>
		
	
		
		
		<li><a href="#DemaisProducaoTecnica">Cartas, mapas ou similares</a></li>
		
	
		
		
		<li><a href="#DemaisProducaoTecnica">Curso de curta duração ministrado</a></li>
		
	
		
		
		<li><a href="#DemaisProducaoTecnica">Desenvolvimento de material didático ou instrucional</a></li>
		
	
		
		
		<li><a href="#DemaisProducaoTecnica">Editoração</a></li>
		
	
		
		
		<li><a href="#ManutencaoObraArtistica">Manutenção de obra artística</a></li>
		
	
		
		
		<li><a href="#DemaisProducaoTecnica">Maquete</a></li>
		
	
		
		
		<li><a href="#EntrevistasMesasRedondas">Entrevistas, mesas redondas, programas e comentários na mídia</a></li>
		
	
		
		
		<li><a href="#DemaisProducaoTecnica">Relatório de pesquisa</a></li>
		
	
		
		
		<li><a href="#RedesSociais">Redes sociais, websites e blogs</a></li>
		
	
		
		
		<li><a href="#DemaisProducoesTecnicas">Outras produções técnicas</a></li>
		
	</ul></div><div class='column'><div class='subtitMenu'><a href='#ProducaoArtisticaCultural'>Produção Artística/Cultural</a></div><h3></h3><ul>
		
		
		<li><a href="#ArtesCenicas">Artes cênicas</a></li>
		
	
		
		
		<li><a href="#Musica">Música</a></li>
		
	
		
		
		<li><a href="#ArtesVisuais">Artes visuais</a></li>
		
	
		
		
		<li><a href="#OutrasProducoesArtisticas">Outras produções artísticas/culturais</a></li>
		
	</ul></div>
		
		
		<div class="clear"></div></div>
		
	<script type='text/javascript'>menu.iniciar("eventos");</script>
		
		
		<a id="ancora-menu-eventos" href="#Eventos" class="acessibilidade separador"><span></span>Eventos</a>
		
	
		
		
		<div id="menu-eventos" class="megamenu">
		
		<div class='column'><h3></h3><ul>
		
		
		<li><a href="#ParticipacaoEventos">Participação em eventos, congressos, exposições e feiras</a></li>
		
	</ul></div>
		
		
		<div class="clear"></div></div>
		
	<script type='text/javascript'>menu.iniciar("informacoes-complementares");</script>
		
		
		<a id="ancora-menu-informacoes-complementares" href="javascript:void(0)" class="acessibilidade separador"><span></span>+</a>
		
	
		
		
		<div id="menu-informacoes-complementares" class="megamenu">
		
		<div class='column'><h3></h3><ul>
		
		
		<li><a href="visualizacv.do?metodo=apresentar&id=K4475230A2&tipo=completo&idiomaExibicao=1">Mostrar informações complementares</a></li>
		
	</ul></div>
		
		
		<div class="clear"></div></div>
		
	</div>
</div>
</div>
</div>
</div>
<div class="content-wrapper">
<div class="main-content max-width min-width center">
<div class="layout-cell layout-cell-12">
<div class="layout-cell-pad-main">
<img class="foto" src="http://servicosweb.cnpq.br/wspessoa/servletrecuperafoto?tipo=1&amp;id=K4475230A2"><div class="infpessoa">
<h2 class="nome">Andre Tesainer Brunetto</h2>
<ul class="informacoes-autor">
<li>
<span class="img_link icone-informacao-autor"></span>Endere&ccedil;o para acessar este CV: http://lattes.cnpq.br/8913704029973970</li>
<li>
<span class="img_cert icone-informacao-autor"></span>&Uacute;ltima atualiza&ccedil;&atilde;o do curr&iacute;culo em 13/07/2019</li>
</ul>
</div><br class="clear" /><div class="title-wrapper">
<h1 class="ui-hidden"></h1>
<hr class="separator">
<p class="resumo">Possui graduação em Medicina pela Pontifícia Universidade Católica do Rio Grande do Sul (2002) e residencia médica em Medicina Interna pelo Hospital de Clínicas de Porto Alegre (HCPA, 2004). Possui mestrado em Oncologia Básica, Clinica e Radioterapia - Universidade de Londres (2009). 
Possui especilização em Oncologia Clinica no Royal Marsden Hospital, Londres (2006-2010) e experiencia clinica em estudos de fase I, II e III quando trabalhou no Drug Development Unit e no Royal Marsden Hospital (2006-2010). Atualmente atua como médico Oncologista e pesquisador na Clínica CliniOnco Porto Alegre e Hospital Moinhos de Vento, Porto Alegre. 
Coordenador científico do centro de pesquisa do Instituto do Cancer Infantil (ICI), RS, BR.<span style="font-weight: bold" class="texto"> (Texto informado pelo autor)</span>
</p>
</div><br class="clear" /><div class="title-wrapper">
<a name="Identificacao">
<h1>Identifica&ccedil;&atilde;o</h1>
</a>
<hr class="separator">
<div class="layout-cell layout-cell-12 data-cell">
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>Nome</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Andre Tesainer Brunetto<img src='/buscatextual/images/icon-rfb.png' class='alinhamento-texto-img'  title='Dados cadastrais validados junto a Receita Federal do Brasil' /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>Nome em citações bibliográficas</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">BRUNETTO, A. T.;Brunetto, Andre T.;Brunetto, A T;Brunetto, André T;Tesainer Brunetto, A.;Brunetto, Andre;Brunetto, A.T.;Tesainer Brunetto, Andre;Brunetto, Andre Tesainer;Brunetto, André;Brunetto, A.;BRUNETTO, ANDRÉ T.;BRUNETTO, ANDRÉ TESAINER;BRUNETTO, ANDRÏ'½</div>
</div>
</div>
</div><br class="clear" /><div class="title-wrapper">
<a name="Endereco">
<h1>Endere&ccedil;o</h1>
</a>
<hr class="separator">
<div class="layout-cell layout-cell-12 data-cell">
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>Endereço Profissional</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Instituto do Câncer Infantil do Rio Grande do Sul. <br class="clear" />Rua São Manoel<br class="clear" />Rio Branco<br class="clear" />90620110 - Porto Alegre, RS - Brasil<br class="clear" />Telefone: (51) 33318704</div>
</div>
</div><br class="clear" /></div><br class="clear" /><div class="title-wrapper">
<a name="FormacaoAcademicaTitulacao">
<h1>Forma&ccedil;&atilde;o acad&ecirc;mica/titula&ccedil;&atilde;o</h1>
</a>
<hr class="separator">
<div class="layout-cell layout-cell-12 data-cell">
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2008 - 2009</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Mestrado em Oncologia Basica, Clinica e Radioterapia<span class="ajaxCAPES" data-param="&codigoCurso=&nivelCurso=M"></span>. <br class="clear" />University of London, UL, Inglaterra.
		
	<br class="clear" />Título: Advanced colorectal cancer (ACRC) and phase I trials: an evidence based approach from referring physician to trial participation.,Ano de Obtenção: 2009.<br class="clear" />Orientador: Professor Stan Kaye.<br class="clear" />Bolsista do(a): Institute of Cancer Research, ICR, Inglaterra. <br class="clear" />Palavras-chave: Estudos de fase 1.<br class="clear" />Grande área: Ciências da Saúde</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2003 - 2005</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Especialização - Residência médica<span class="ajaxCAPES" data-param="&codigoCurso=&nivelCurso="></span>. <br class="clear" />Hospital de Clínicas de Porto Alegre, HCPA, Brasil.
		
	Residência médica em: Clinica Geral<br class="clear" />Número do registro: . <br class="clear" />Bolsista do(a): Ministerio da Edicação e Cultura, MEC, Brasil. </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2011 - 2011</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Especialização em Título Especialista Cancerologia Clínica<span class="ajaxCAPES" data-param="&codigoCurso=&nivelCurso="></span>. <br class="clear" />Sociedade Brasileira Cancerologia, SBC, Brasil.
		
	<br class="clear" />Título: nao aplicável. </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2006 - 2010</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Especialização em Oncologia Clinica<span class="ajaxCAPES" data-param="&codigoCurso=&nivelCurso="></span>. <br class="clear" />Royal Marsden Hospital, RMH, Inglaterra.
		
	<br class="clear" />Título: Especializaçao em Oncologia Clinica. <br class="clear" />Bolsista do(a): Institute of Cancer Research, ICR, Grã-Bretanha. </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2007 - 2008</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Aperfeiçoamento em Diploma em Oncologia<span class="ajaxCAPES" data-param="&codigoCurso=&nivelCurso="></span>. <br class="clear" />University of London, UL, Inglaterra.
		
	<br class="clear" />Título: Diploma em Oncologia. Ano de finalização: 2008. </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2006 - 2007</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Aperfeiçoamento em Certificado em Oncologia Clinica<span class="ajaxCAPES" data-param="&codigoCurso=&nivelCurso="></span>. <br class="clear" />University of London, UL, Inglaterra.
		
	<br class="clear" />Título: Certificado em Oncologia Clinica. Ano de finalização: 2007. </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1997 - 2002</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Graduação em Medicina<span class="ajaxCAPES" data-param="&codigoCurso=&nivelCurso="></span>. <br class="clear" />Pontifícia Universidade Católica do Rio Grande do Sul, PUCRS, Brasil.
		
	<br class="clear" />Título: Monografia: Tumor markers in Clinical Practice. <br class="clear" />Orientador: Bernardo Garicochea. </div>
</div>
</div><br class="clear" /></div><br class="clear" /><div class="title-wrapper">
<div class="layout-cell layout-cell-12 data-cell"></div><br class="clear" /></div><br class="clear" /><div class="title-wrapper">
<a name="FormacaoComplementar">
<h1>Forma&ccedil;&atilde;o Complementar</h1>
</a>
<hr class="separator">
<div class="layout-cell layout-cell-12 data-cell">
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2002 - 2002</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"> Extensão universitária em Estagio curriclular em Oncologia Clinica. <br class="clear" />Hospital de Clínicas de Porto Alegre, HCPA, Brasil.
		
	</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2001 - 2001</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"> Extensão universitária em Estagio curricular em Oncologia Pediatrica. <br class="clear" />Hospital de Clínicas de Porto Alegre, HCPA, Brasil.
		
	</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2001 - 2001</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"> Extensão universitária em Estagio extra-curricular em Oncologia. <br class="clear" />The Johns Hopkins Hospital, JHH, Estados Unidos.
		
	</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2000 - 2000</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"> Extensão universitária em Histocompatibility/hematopoietic cell identif.. <br class="clear" />Lindsley F. Kimball Research, LFKR, Estados Unidos.
		
	</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1999 - 1999</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"> Extensão universitária em Estagio Curricular em Pneumologia. <br class="clear" />Hopsital São Lucas PUC, HSL, Brasil.
		
	</div>
</div>
</div><br class="clear" /></div><br class="clear" /><div class="title-wrapper">
<a name="AtuacaoProfissional">
<h1>Atua&ccedil;&atilde;o Profissional</h1>
</a>
<hr class="separator">
<div class="layout-cell layout-cell-12 data-cell"><br class="clear" /><div class="inst_back">
<b>Hospital Ernesto Dornelles, HED, Brasil.
		
	</b>
</div>
<div class="layout-cell layout-cell-3 text-align-right subtit-1">
<div class="layout-cell-pad-5 text-align-right">
<b>Vínculo institucional</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"><br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2012 - 2018</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Vínculo: Colaborador, Enquadramento Funcional: Membro Colaborador CEP-HED, Carga horária: 2</div>
</div><br class="clear" /><div class="layout-cell layout-cell-3 text-align-right subtit-1">
<div class="layout-cell-pad-5 text-align-right">
<b>Vínculo institucional</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"><br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2011 - 2015</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Vínculo: Colaborador, Enquadramento Funcional: Médico e Pesquisador</div>
</div><br class="clear" /><br class="clear" /><div class="inst_back">
<b>Instituto de Câncer de Brasília, ICB, Brasil.
		
	</b>
</div>
<div class="layout-cell layout-cell-3 text-align-right subtit-1">
<div class="layout-cell-pad-5 text-align-right">
<b>Vínculo institucional</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"><br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2011 - 2014</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Vínculo: Celetista formal, Enquadramento Funcional: Médico pesquisdador</div>
</div><br class="clear" /><br class="clear" /><div class="inst_back">
<b>Instituto Kaplan de Oncologia, KAPLAN, Brasil.
		
	</b>
</div>
<div class="layout-cell layout-cell-3 text-align-right subtit-1">
<div class="layout-cell-pad-5 text-align-right">
<b>Vínculo institucional</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"><br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2010 - 2014</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Vínculo: Celetista formal, Enquadramento Funcional: Medico Oncologista</div>
</div><br class="clear" /><br class="clear" /><div class="inst_back">
<b>Fundação Central Sul Americana para o Desenvol. de Drogas Anti-Câncer, SOAD, Brasil.
		
	</b>
</div>
<div class="layout-cell layout-cell-3 text-align-right subtit-1">
<div class="layout-cell-pad-5 text-align-right">
<b>Vínculo institucional</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"><br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2010 - 2014</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Vínculo: Celetista formal, Enquadramento Funcional: Médico pesquisador</div>
</div><br class="clear" /><br class="clear" /><div class="inst_back">
<b>American Society of Clinical Oncology, ASCO, Estados Unidos.
		
	</b>
</div>
<div class="layout-cell layout-cell-3 text-align-right subtit-1">
<div class="layout-cell-pad-5 text-align-right">
<b>Vínculo institucional</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"><br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2009 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Vínculo: Membro, Enquadramento Funcional: Membro</div>
</div><br class="clear" /><br class="clear" /><div class="inst_back">
<b>European Society of Clinical Oncology, ESMO, Suiça.
		
	</b>
</div>
<div class="layout-cell layout-cell-3 text-align-right subtit-1">
<div class="layout-cell-pad-5 text-align-right">
<b>Vínculo institucional</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"><br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2008 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Vínculo: Membro, Enquadramento Funcional: Membro</div>
</div><br class="clear" /><br class="clear" /><div class="inst_back">
<b>Royal Marsden Hospital, RMH, Inglaterra.
		
	</b>
</div>
<div class="layout-cell layout-cell-3 text-align-right subtit-1">
<div class="layout-cell-pad-5 text-align-right">
<b>Vínculo institucional</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"><br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2009 - 2010</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Vínculo: Celetista formal, Enquadramento Funcional: Clinical Research Fellow Renal and Melanoma, Carga horária: 10</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>Outras informações</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Supervisores: Martin Gore, Dr James Larkin and Dr Lisa Pickering</div>
</div><br class="clear" /><div class="layout-cell layout-cell-3 text-align-right subtit-1">
<div class="layout-cell-pad-5 text-align-right">
<b>Vínculo institucional</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"><br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2008 - 2010</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Vínculo: Celetista formal, Enquadramento Funcional: Clinical Research Fellow Phase 1 unit, Carga horária: 40</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>Outras informações</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Supervisores: Professor Stan Kaye, Dr Johann de-Bono and Dr Udai Banerji</div>
</div><br class="clear" /><div class="layout-cell layout-cell-3 text-align-right subtit-1">
<div class="layout-cell-pad-5 text-align-right">
<b>Vínculo institucional</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"><br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2008 - 2009</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Vínculo: Celetista formal, Enquadramento Funcional: Clinical Research Fellow Gynae and Sarcoma, Carga horária: 10</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>Outras informações</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Supervisores: Professor Stan Kaye and Professor Ian Judson</div>
</div><br class="clear" /><div class="layout-cell layout-cell-3 text-align-right subtit-1">
<div class="layout-cell-pad-5 text-align-right">
<b>Vínculo institucional</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"><br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2007 - 2008</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Vínculo: Celetista formal, Enquadramento Funcional: Clinical Research Fellow GI and Lymphoma, Carga horária: 40, Regime: Dedicação exclusiva. </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>Outras informações</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Supervisores: Professor David Cunningham and Dr Ian Chau</div>
</div><br class="clear" /><div class="layout-cell layout-cell-3 text-align-right subtit-1">
<div class="layout-cell-pad-5 text-align-right">
<b>Vínculo institucional</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"><br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2007 - 2007</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Vínculo: Celetista formal, Enquadramento Funcional: Clinical Research Fellow Lung Unit, Carga horária: 40, Regime: Dedicação exclusiva. </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>Outras informações</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Supervisores: Dr Mary O?Brien and Dr Sanjay Popat.</div>
</div><br class="clear" /><div class="layout-cell layout-cell-3 text-align-right subtit-1">
<div class="layout-cell-pad-5 text-align-right">
<b>Vínculo institucional</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"><br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2006 - 2006</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Vínculo: Celetista formal, Enquadramento Funcional: Clinical Research Fellow Breast Unit, Carga horária: 40, Regime: Dedicação exclusiva. </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>Outras informações</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Supervisores: Professor Ian Smith and Dr Stephen Johnston</div>
</div><br class="clear" /><div class="layout-cell layout-cell-3 text-align-right subtit-1">
<div class="layout-cell-pad-5 text-align-right">
<b>Atividades</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"><br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>06/2006 - 01/2010</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Pesquisa e desenvolvimento , Department of Oncology, . </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Linhas de pesquisa <br class="clear" /><a href='#LP_Estudos de fase 1, 2, 3 em Oncologia'>Estudos de fase 1, 2, 3 em Oncologia</a><br class="clear" /><a href='#LP_Participação em estudos de phase 1 com responsabilidade:monitoramento de dados;escrever protocolos de pesquisa; recrutamento de pacientes; participação em teleconferencias para decisao de ajuste de dose, toxicidade e avaliação farmacodinamica.'>Participação em estudos de phase 1 com responsabilidade:monitoramento de dados;escrever protocolos de pesquisa; recrutamento de pacientes; participação em teleconferencias para decisao de ajuste de dose, toxicidade e avaliação farmacodinamica.</a><br class="clear" /><a href='#LP_Atuação com subinvestigador em diversos estudos de fase 2 e 3 em cancer de mama, pulmão, coloretal, sarcoma , melanoma e tumores ginecológicos.'>Atuação com subinvestigador em diversos estudos de fase 2 e 3 em cancer de mama, pulmão, coloretal, sarcoma , melanoma e tumores ginecológicos.</a><br class="clear" /></div>
</div><br class="clear" /><div class="inst_back">
<b>CliniOnco, CLINOONCO, Brasil.
		
	</b>
</div>
<div class="layout-cell layout-cell-3 text-align-right subtit-1">
<div class="layout-cell-pad-5 text-align-right">
<b>Vínculo institucional</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"><br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2014 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Vínculo: Colaborador, Enquadramento Funcional: Oncologista e pesquisador, Carga horária: 10</div>
</div><br class="clear" /><br class="clear" /><div class="inst_back">
<b>Instituto do Câncer Infantil do Rio Grande do Sul, ICI, Brasil.
		
	</b>
</div>
<div class="layout-cell layout-cell-3 text-align-right subtit-1">
<div class="layout-cell-pad-5 text-align-right">
<b>Vínculo institucional</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"><br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2015 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Vínculo: Consultor contratado, Enquadramento Funcional: Coordenador Centro de Pesquisas, Carga horária: 20</div>
</div><br class="clear" /><br class="clear" /><div class="inst_back">
<b>Hospital Moinhos de Vento, HMV, Brasil.
		
	</b>
</div>
<div class="layout-cell layout-cell-3 text-align-right subtit-1">
<div class="layout-cell-pad-5 text-align-right">
<b>Vínculo institucional</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5"><br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2014 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Vínculo: Médico Oncologista, Enquadramento Funcional: Médico Colaborador, Carga horária: 6</div>
</div><br class="clear" /></div><br class="clear" /></div><br class="clear" /><div class="title-wrapper">
<a name="LinhaPesquisa">
<h1>Linhas de pesquisa</h1>
</a>
<hr class="separator">
<div class="layout-cell layout-cell-12 data-cell"><a name='LP_Estudos de fase 1, 2, 3 em Oncologia'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1. </b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Estudos de fase 1, 2, 3 em Oncologia</div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b><br class="clear" /></b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Objetivo: Ensaios Clinicos nao-randomizados e randomizados para desenvolvimento de novas drogas anti-cancer em tumores solidos.. <br class="clear" />Grande área: Ciências da Saúde<br class="clear" />Setores de atividade: Pesquisa e desenvolvimento científico. <br class="clear" />Palavras-chave: Cancer; Estudos de fase 1; Estudos de fase 2 e 3; Estudos Clinicos.</div>
</div><a name='LP_Participa&ccedil;&atilde;o em estudos de phase 1 com responsabilidade:monitoramento de dados;escrever protocolos de pesquisa; recrutamento de pacientes; participa&ccedil;&atilde;o em teleconferencias para decisao de ajuste de dose, toxicidade e avalia&ccedil;&atilde;o farmacodinamica.'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2. </b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Participação em estudos de phase 1 com responsabilidade:monitoramento de dados;escrever protocolos de pesquisa; recrutamento de pacientes; participação em teleconferencias para decisao de ajuste de dose, toxicidade e avaliação farmacodinamica.</div>
</div><a name='LP_Atua&ccedil;&atilde;o com subinvestigador em diversos estudos de fase 2 e 3 em cancer de mama, pulm&atilde;o, coloretal, sarcoma , melanoma e tumores ginecol&oacute;gicos.'></a><div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>3. </b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Atuação com subinvestigador em diversos estudos de fase 2 e 3 em cancer de mama, pulmão, coloretal, sarcoma , melanoma e tumores ginecológicos.</div>
</div>
</div><br class="clear" /></div><br class="clear" /><div class="title-wrapper">
<a name="RevisorPeriodico">
<h1>Revisor de peri&oacute;dico</h1>
</a>
<hr class="separator">
<div class="layout-cell layout-cell-12 data-cell">
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2010 - Atual</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Periódico: Future Oncology Group</div>
</div>
</div><br class="clear" /></div><br class="clear" /><div class="title-wrapper">
<a name="AreasAtuacao">
<h1>&Aacute;reas de atua&ccedil;&atilde;o</h1>
</a>
<hr class="separator">
<div class="layout-cell layout-cell-12 data-cell">
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1. </b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Grande área: Ciências da Saúde / Área: Medicina / Subárea: Oncologia. <br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2. </b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Grande área: Ciências da Saúde / Área: Medicina / Subárea: Oncologia/Especialidade: Estudos de Phase 1 em Oncologia. <br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>3. </b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Grande área: Ciências da Saúde / Área: Medicina / Subárea: Oncologia/Especialidade: Estudos de Phase 2 em Oncologia. <br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>4. </b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Grande área: Ciências da Saúde / Área: Medicina / Subárea: Oncologia/Especialidade: Estudos de Phase 3 em Oncologia. <br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>5. </b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Grande área: Ciências da Saúde / Área: Medicina / Subárea: Clínica Médica. <br class="clear" /></div>
</div>
</div><br class="clear" /></div><br class="clear" /><div class="title-wrapper">
<a name="Idiomas">
<h1>Idiomas</h1>
</a>
<hr class="separator">
<div class="layout-cell layout-cell-12 data-cell">
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>Inglês</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Compreende Bem, Fala Bem, Lê Bem, Escreve Bem. </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>Português</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Compreende Bem, Fala Bem, Lê Bem, Escreve Bem. </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>Espanhol</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Compreende Bem, Fala Razoavelmente, Lê Razoavelmente, Escreve Pouco. </div>
</div>
</div><br class="clear" /></div><br class="clear" /><div class="title-wrapper">
<a name="PremiosTitulos">
<h1>Pr&ecirc;mios e t&iacute;tulos</h1>
</a>
<hr class="separator">
<div class="layout-cell layout-cell-12 data-cell">
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2009</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Merit award, American Society of Clinical Oncology (ASCO). </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2009</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Travel award, European Society of Clinical Oncology (ESMO) - ECCLU. </div>
</div>
</div><br class="clear" /></div><br class="clear" /><div class="title-wrapper">
<a name="ProducoesCientificas">
<h1>Produ&ccedil;&otilde;es</h1>
</a>
<hr class="separator">
<div class="layout-cell layout-cell-12 data-cell">
<a name="ProducaoBibliografica"></a><br class="clear" /><div class="inst_back">
<b>Produção bibliográfica</b>
</div>
<a name="Citacoes"></a>
<div id="artigos-completos">
<div class="cita-artigos">
<b><a name="ArtigosCompletos"></a>Artigos completos publicados em periódicos</b>
</div><br class="clear" /><div class="layout-cell-6">
<div class="sub_tit_form">
<label for="combo-ordenacao-citacao">Ordenar por</label><select class="input-text input-login-select" id="combo-ordenacao-citacao"><option value="1"> Ordem Cronol&oacute;gica </option><option value="2"> N&uacute;mero de cita&ccedil;&otilde;es Web of science </option><option value="3"> N&uacute;mero de cita&ccedil;&otilde;es Scopus </option><option value="4"> Numero de cita&ccedil;&otilde;es Scielo </option><option value="5"> Primeiro autor </option><option value="6"> Impacto JCR </option><option value="7"> Ordem de Import&acirc;ncia </option></select>
</div>
</div>
<script type="text/javascript">
			
				var ordenacao = {
					engine: {
						textual: function(seletor) {
						
							$("#artigos-completos").find(".artigo-completo").sortElements(function(a, b){
								var v1 = $(a).find(seletor).text();
								var v2 = $(b).find(seletor).text();
								return (v1 > v2) ? 1 : -1;
							});
						},
						numerico: function(seletor) {
						
							$("#artigos-completos").find(".artigo-completo").sortElements(function(a, b){
								var v1 = parseInt($(a).find(seletor).text(), 10);
								var v2 = parseInt($(b).find(seletor).text(), 10);
								if (isNaN(v1)) v1 = 0;
								if (isNaN(v1)) v2 = 0;
								return (v1 < v2) ? 1 : -1;
							});
						},
						numerico_crescente: function(seletor) {
						
							$("#artigos-completos").find(".artigo-completo").sortElements(function(a, b){
								var v1 = parseInt($(a).find(seletor).text(), 10);
								var v2 = parseInt($(b).find(seletor).text(), 10);
								if (isNaN(v1)) v1 = 0;
								if (isNaN(v1)) v2 = 0;
								return (v1 > v2) ? 1 : -1;
							});
						}
					},
					change: function(e) {
					
						var combo = $(e.target),
							valor = combo.val();
							
						if (valor == 1) ordenacao.engine.numerico("span[data-tipo-ordenacao='ano']");
						if (valor == 2) ordenacao.engine.numerico("span[data-tipo-ordenacao='1']");
						if (valor == 3) ordenacao.engine.numerico("span[data-tipo-ordenacao='3']");						
						if (valor == 4) ordenacao.engine.numerico("span[data-tipo-ordenacao='2']");
						if (valor == 5) ordenacao.engine.textual("span[data-tipo-ordenacao='autor']");
						if (valor == 6) ordenacao.engine.numerico("span[data-tipo-ordenacao='jcr']");
						if (valor == 7) ordenacao.engine.numerico_crescente("span[data-tipo-ordenacao='importancia']");
							
					}
				};
			
				$("#combo-ordenacao-citacao").bind("change", ordenacao.change);
			
			</script>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>ANTUNES, BRUNO PEREIRA</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2019</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1590/0100-6991e-20192094" target="_blank"></a>ANTUNES, BRUNO PEREIRA ; BECKER, RICARDO GEHRKE ; <b>BRUNETTO, ANDRÉ TESAINER</b> ; PAVEI, BRUNO SILVEIRA ; DE-FARIAS, CAROLINE BRUNETTO ; RIVERO, LUÍS FERNANDO DA ROSA ; SANTOS, JULIE FRANCINE CERUTTI ; DE-OLIVEIRA, BRUNA MEDEIROS ; Gregianin, Lauro José ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/6516219295405539" target="_blank">Roesler, Rafael</a> ; Brunetto, Algemir Lunardi ; PAGNUSSATO, FERNANDO ; GALIA, CARLOS ROBERTO . Expressão de neurotrofinas e de seus receptores no osteossarcoma primário.. REVISTA DO COLÉGIO BRASILEIRO DE CIRURGIÕES (ONLINE)<sup><img id='18094546_1' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='18094546' /></sup>, v. 46, p. e2094, 2019. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1590/0100-6991e-20192094&issn=18094546&volume=46&issue=&paginaInicial=e2094&titulo=Expressão de neurotrofinas e de seus receptores no osteossarcoma primário.&sequencial=1&nomePeriodico=REVISTA DO COLÉGIO BRASILEIRO DE CIRURGIÕES (ONLINE)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>BUENDIA DUQUE, MARIENELA</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2019</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1007/s12031-019-01280-5" target="_blank"></a>BUENDIA DUQUE, MARIENELA ; PINHEIRO, KELLY DE VARGAS ; THOMAZ, AMANDA ; DA SILVA, CAMILA ALVES ; FREIRE, NATÁLIA HOGETOP ; <b>BRUNETTO, ANDRÉ TESAINER</b> ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/9574856139602553" target="_blank">Schwartsmann, Gilberto</a> ; JAEGER, MARIANE ; de Farias, Caroline Brunetto ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/6516219295405539" target="_blank">Roesler, Rafael</a> . Combined Inhibition of HDAC and EGFR Reduces Viability and Proliferation and Enhances STAT3 mRNA Expression in Glioblastoma Cells. JOURNAL OF MOLECULAR NEUROSCIENCE<sup><img id='08958696_2' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='08958696' /></sup>, v. 1, p. 49-57, 2019. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1007/s12031-019-01280-5&issn=08958696&volume=1&issue=&paginaInicial=49&titulo=Combined Inhibition of HDAC and EGFR Reduces Viability and Proliferation and Enhances STAT3 mRNA Expression in Glioblastoma Cells&sequencial=2&nomePeriodico=JOURNAL OF MOLECULAR NEUROSCIENCE" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>3. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>THOMAZ, AMANDA</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2019</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.3389/fphar.2019.00698" target="_blank"></a>THOMAZ, AMANDA ; PINHEIRO, KELLY DE VARGAS ; SOUZA, BÁRBARA KUNZLER ; GREGIANIN, LAURO ; BRUNETTO, ALGEMIR L. ; <b>BRUNETTO, ANDRÉ T.</b> ; de Farias, Caroline Brunetto ; JAEGER, MARIANE DA CUNHA ; RAMASWAMY, VIJAY ; NÖR, CAROLINA ; TAYLOR, MICHAEL D. ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/6516219295405539" target="_blank">Roesler, Rafael</a> . Antitumor Activities and Cellular Changes Induced by TrkB Inhibition in Medulloblastoma. Frontiers in Pharmacology<sup><img id='16639812_3' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='16639812' /></sup>, v. 10, p. 1-1, 2019. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.3389/fphar.2019.00698&issn=16639812&volume=10&issue=&paginaInicial=1&titulo=Antitumor Activities and Cellular Changes Induced by TrkB Inhibition in Medulloblastoma&sequencial=3&nomePeriodico=Frontiers in Pharmacology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>4. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>SOUZA, BÁRBARA KUNZLER</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2018</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1007/s12035-018-0874-6" target="_blank"></a>SOUZA, BÁRBARA KUNZLER ; DA COSTA LOPEZ, PATRÍCIA LUCIANA ; MENEGOTTO, PÂMELA ROSSI ; VIEIRA, IGOR ARAUJO ; KERSTING, NATHALIA ; ABUJAMRA, ANA LÚCIA ; <b>BRUNETTO, ANDRÉ T.</b> ; BRUNETTO, ALGEMIR L. ; GREGIANIN, LAURO ; de Farias, Caroline Brunetto ; THIELE, CAROL J. ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/6516219295405539" target="_blank">Roesler, Rafael</a> . Targeting Histone Deacetylase Activity to Arrest Cell Growth and Promote Neural Differentiation in Ewing Sarcoma. MOLECULAR NEUROBIOLOGY<sup><img id='08937648_4' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='08937648' /></sup>, v. 1, p. 1-17, 2018. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1007/s12035-018-0874-6&issn=08937648&volume=1&issue=&paginaInicial=1-17&titulo=Targeting Histone Deacetylase Activity to Arrest Cell Growth and Promote Neural Differentiation in Ewing Sarcoma&sequencial=4&nomePeriodico=MOLECULAR NEUROBIOLOGY" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>5. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>HORBACH, LEONARDO</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2018</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.3892/mco.2018.1608" target="_blank"></a>HORBACH, LEONARDO ; SINIGAGLIA, MARIALVA ; DA SILVA, CAMILA ; OLGUINS, DANIELLY ; GREGIANIN, LAURO ; BRUNETTO, ALGEMIR ; <b>BRUNETTO, ANDRÏ'½</b> ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/6516219295405539" target="_blank">Roesler, Rafael</a> ; DE FARIAS, CAROLINE . Gene expression changes associated with chemotherapy resistance in Ewing sarcoma cells. MOLECULAR AND CLINICAL ONCOLOGY<sup><img id='20499450_5' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='20499450' /></sup>, v. 8, p. 719-724, 2018. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.3892/mco.2018.1608&issn=20499450&volume=8&issue=&paginaInicial=719-724&titulo=Gene expression changes associated with chemotherapy resistance in Ewing sarcoma cells&sequencial=5&nomePeriodico=MOLECULAR AND CLINICAL ONCOLOGY" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>6. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>HEINEN, TIAGO ELIAS</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2016</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.18632/oncotarget.8992" target="_blank"></a>HEINEN, TIAGO ELIAS ; SANTOS, RAFAEL PEREIRA DOS ; ROCHA, AMANDA DA ; SANTOS, MICHEL PINHEIRO DO ; LOPEZ, PATRÍCIA LUCIANA DA COSTA ; FILHO, MARCO AURÉLIO SILVA ; SOUZA, BÁRBARA KUNZLER ; RIVERO, LUÍS FERNANDO DA ROSA ; BECKER, RICARDO GEHRKE ; Gregianin, Lauro José ; Brunetto, Algemir Lunardi ; <b>BRUNETTO, ANDRÉ TESAINER</b> ; FARIAS, CAROLINE BRUNETTO DE ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/6516219295405539" target="_blank">Roesler, Rafael</a> . Trk inhibition reduces cell proliferation and potentiates the effects of chemotherapeutic agents in Ewing sarcoma. OncoTarget<sup><img id='19492553_6' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='19492553' /></sup>, v. 23, p. 34860-80, 2016. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.18632/oncotarget.8992&issn=19492553&volume=23&issue=&paginaInicial=34860&titulo=Trk inhibition reduces cell proliferation and potentiates the effects of chemotherapeutic agents in Ewing sarcoma&sequencial=6&nomePeriodico=OncoTarget" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>7. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>PORTICH, JÚLIA PLENTZ</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2016</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.3233/cbm-160646" target="_blank"></a>PORTICH, JÚLIA PLENTZ ; GIL, MIRELA SEVERO ; DOS SANTOS, RAFAEL PEREIRA ; GOULART, BRUNO KILPP ; FERREIRA, MARIA BEATRIZ CARDOSO ; LOSS, JISEH FAGUNDES ; Gregianin, Lauro José ; Brunetto, Algemir Lunardi ; <b>BRUNETTO, ANDRÉ TESAINER</b> ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/6516219295405539" target="_blank">Roesler, Rafael</a> ; de Farias, Caroline Brunetto . Low brain-derived neurotrophic factor levels are associated with active disease and poor prognosis in childhood acute leukemia. Cancer Biomarkers<sup><img id='15740153_7' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='15740153' /></sup>, v. 17, p. 347-352, 2016. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.3233/cbm-160646&issn=15740153&volume=17&issue=&paginaInicial=347&titulo=Low brain-derived neurotrophic factor levels are associated with active disease and poor prognosis in childhood acute leukemia&sequencial=7&nomePeriodico=Cancer Biomarkers" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>8. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>ALMEIDA, VIVIANE RÖSNER</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2016</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1007/s12035-016-0250-3" target="_blank"></a>ALMEIDA, VIVIANE RÖSNER ; VIEIRA, IGOR ARAUJO ; BUENDIA, MARIENELA ; <b>BRUNETTO, ANDRÉ TESAINER</b> ; GREGIANIN, LAURO J. ; Brunetto, Algemir Lunardi ; KLAMT, FÁBIO ; de Farias, Caroline Brunetto ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/8486464868891415" target="_blank">Abujamra, Ana Lucia</a> ; LOPEZ, PATRÍCIA LUCIANA DA COSTA ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/6516219295405539" target="_blank">Roesler, Rafael</a> . Combined Treatments with a Retinoid Receptor Agonist and Epigenetic Modulators in Human Neuroblastoma Cells. Molecular Neurobiology<sup><img id='08937648_8' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='08937648' /></sup>, v. 00, p. 00, 2016. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1007/s12035-016-0250-3&issn=08937648&volume=00&issue=&paginaInicial=00&titulo=Combined Treatments with a Retinoid Receptor Agonist and Epigenetic Modulators in Human Neuroblastoma Cells&sequencial=8&nomePeriodico=Molecular Neurobiology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>9. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>JAEGER, MARIANE</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2015</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1007/s00381-015-2963-4" target="_blank"></a>JAEGER, MARIANE ; GHISLENI, EDUARDA C. ; FRATINI, LÍVIA ; BRUNETTO, ALGEMIR L. ; Gregianin, Lauro José ; <b>BRUNETTO, ANDRÉ T.</b> ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/9574856139602553" target="_blank">Schwartsmann, Gilberto</a> ; DE FARIAS, CAROLINE B. ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/6516219295405539" target="_blank">Roesler, Rafael</a> . Viability of D283 medulloblastoma cells treated with a histone deacetylase inhibitor combined with bombesin receptor antagonists. Child's Nervous System (Print)<sup><img id='02567040_9' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='02567040' /></sup>, v. 32, p. 61, 2015. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1007/s00381-015-2963-4&issn=02567040&volume=32&issue=&paginaInicial=61&titulo=Viability of D283 medulloblastoma cells treated with a histone deacetylase inhibitor combined with bombesin receptor antagonists&sequencial=9&nomePeriodico=Child's Nervous System (Print)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>10. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>THOMAZ, AMANDA</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2015</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1007/s12031-015-0689-0" target="_blank"></a>THOMAZ, AMANDA ; JAEGER, MARIANE ; BUENDIA, MARIENELA ; BAMBINI-JUNIOR, VICTORIO ; Gregianin, Lauro José ; Brunetto, Algemir Lunardi ; <b>BRUNETTO, ANDRÉ T.</b> ; de Farias, Caroline Brunetto ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/6516219295405539" target="_blank">Roesler, Rafael</a> . BDNF/TrkB Signaling as a Potential Novel Target in Pediatric Brain Tumors: Anticancer Activity of Selective TrkB Inhibition in Medulloblastoma Cells. Journal of Molecular Neuroscience<sup><img id='08958696_10' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='08958696' /></sup>, v. 8, p. 1, 2015. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1007/s12031-015-0689-0&issn=08958696&volume=8&issue=&paginaInicial=1&titulo=BDNF/TrkB Signaling as a Potential Novel Target in Pediatric Brain Tumors: Anticancer Activity of Selective TrkB Inhibition in Medulloblastoma Cells&sequencial=10&nomePeriodico=Journal of Molecular Neuroscience" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>11. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Mattei, Jane</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2014</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.5858/arpa.2012-0679-oa" target="_blank"></a>Mattei, Jane ; ACHCAR, ROSANE D. ; CANO, CARLOS H. ; MACEDO, BRUNO R. ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/2731053340951737" target="_blank">MEURER, LUISE</a> ; BATLLE, BRENDA S. ; GROSHONG, STEVE D. ; KULCZYNSKI, JANE M. ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/6516219295405539" target="_blank">Roesler, Rafael</a> ; DAL LAGO, LISSANDRA ; <b>Brunetto, Andre T.</b> ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/9574856139602553" target="_blank">Schwartsmann, Gilberto</a> . Gastrin-Releasing Peptide Receptor Expression in Lung Cancer. Archives of Pathology & Laboratory Medicine (1976)<sup><img id='00039985_11' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='00039985' /></sup>, v. 138, p. 98-104, 2014. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.5858/arpa.2012-0679-oa&issn=00039985&volume=138&issue=&paginaInicial=98&titulo=Gastrin-Releasing Peptide Receptor Expression in Lung Cancer&sequencial=11&nomePeriodico=Archives of Pathology & Laboratory Medicine (1976)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>12. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>MOLIFE, L. R.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2014</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1158/1078-0432.CCR-14-0409" target="_blank"></a>MOLIFE, L. R. ; DEAN, E. J. ; Blanco-Codesido, M. ; KREBS, M. G. ; <b>BRUNETTO, A. T.</b> ; GREYSTOKE, A. P. ; DANIELE, G. ; LEE, L. ; KUZNETSOV, G. ; MYINT, K. T. ; WOOD, K. ; DE LAS HERAS, B. ; RANSON, M. R. . A Phase I, Dose-Escalation Study of the Multitargeted Receptor Tyrosine Kinase Inhibitor, Golvatinib, in Patients with Advanced Solid Tumors. Clinical Cancer Research (Print)<sup><img id='10780432_12' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='10780432' /></sup>, v. 20, p. 6284-6294, 2014. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1158/1078-0432.CCR-14-0409&issn=10780432&volume=20&issue=&paginaInicial=6284&titulo=A Phase I, Dose-Escalation Study of the Multitargeted Receptor Tyrosine Kinase Inhibitor, Golvatinib, in Patients with Advanced Solid Tumors&sequencial=12&nomePeriodico=Clinical Cancer Research (Print)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>13. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>MORENO GARCIA, V.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2014</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1158/1078-0432.CCR-14-0719" target="_blank"></a>MORENO GARCIA, V. ; Olmos, D. ; Gomez-Roca, C. ; CASSIER, P. A. ; MORALES-BARRERA, R. ; del Conte, G. ; Gallerani, E. ; <b>BRUNETTO, A. T.</b> ; Schoffski, P. ; Marsoni, S. ; SCHELLENS, J. H. M. ; Penel, N. ; VOEST, E. ; EVANS, J. ; Plummer, R. ; WILSON, R. H. ; SORIA, J. C. ; Tabernero, J. ; Verweij, J. ; Kaye, S. B. . Dose-Response Relationship in Phase I Clinical Trials: A European Drug Development Network (EDDN) Collaboration Study. Clinical Cancer Research (Print)<sup><img id='10780432_13' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='10780432' /></sup>, v. 20, p. 5663-5671, 2014. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1158/1078-0432.CCR-14-0719&issn=10780432&volume=20&issue=&paginaInicial=5663&titulo=Dose-Response Relationship in Phase I Clinical Trials: A European Drug Development Network (EDDN) Collaboration Study&sequencial=13&nomePeriodico=Clinical Cancer Research (Print)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>14. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>BRUNETTO, A. T.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2013</span>
		<img src="images/curriculo/ico_relevante.gif" style='icone-relevancia' />
		<a class="icone-producao icone-doi" href="http://dx.doi.org/10.1158/1078-0432.CCR-13-0735" target="_blank"></a><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/8913704029973970" target="_blank">BRUNETTO, A. T.</a></b>; Ang, J. E. ; Lal, R. ; Olmos, D. ; MOLIFE, L. R. ; Kristeleit, R. ; PARKER, A. ; CASAMAYOR, I. ; OLALEYE, M. ; Mais, A. ; Hauns, B. ; STROBEL, V. ; Hentsch, B. ; de Bono, J. S. . First-in-human, Pharmacokinetic and Pharmacodynamic Phase I Study of Resminostat, an Oral Histone Deacetylase Inhibitor, in Patients with Advanced Solid Tumors. Clinical Cancer Research (Print)<sup><img id='10780432_14' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='10780432' /></sup>, v. 19, p. 5494-5504, 2013. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1158/1078-0432.CCR-13-0735&issn=10780432&volume=19&issue=&paginaInicial=5494&titulo=First-in-human, Pharmacokinetic and Pharmacodynamic Phase I Study of Resminostat, an Oral Histone Deacetylase Inhibitor, in Patients with Advanced Solid Tumors&sequencial=14&nomePeriodico=Clinical Cancer Research (Print)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>15. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Olmos, D.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2012</span>
		<img src="images/curriculo/ico_relevante.gif" style='icone-relevancia' />
		<a class="icone-producao icone-doi" href="http://dx.doi.org/10.1200/JCO.2010.34.5074" target="_blank"></a>Olmos, D. ; A&amp ; Marsoni, S. ; Morales, R. ; Gomez-Roca, C. ; Verweij, J. ; Voest, E. E. ; Schoffski, P. ; Ang, J. E. ; Penel, N. ; Schellens, J. H. ; del Conte, G. ; <b>BRUNETTO, A. T.</b> ; Evans, T. R. J. ; Wilson, R. ; Gallerani, E. ; Plummer, R. ; Tabernero, J. ; Soria, J.-C. ; Kaye, S. B. . Patient Selection for Oncology Phase I Trials: A Multi-Institutional Study of Prognostic Factors. Journal of Clinical Oncology<sup><img id='0732183X_15' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='0732183X' /></sup>, v. 30, p. 996-1004, 2012. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1200/JCO.2010.34.5074&issn=0732183X&volume=30&issue=&paginaInicial=996&titulo=Patient Selection for Oncology Phase I Trials: A Multi-Institutional Study of Prognostic Factors&sequencial=15&nomePeriodico=Journal of Clinical Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>16. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>DOS SANTOS, L. V.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2012</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1093/jnci/djs335" target="_blank"></a>DOS SANTOS, L. V. ; SOUZA, F. H. ; <b>BRUNETTO, A. T.</b> ; SASSE, A. D. ; DA SILVEIRA NOGUEIRA LIMA, J. P. . Neurokinin-1 Receptor Antagonists for Chemotherapy-Induced Nausea and Vomiting: A Systematic Review. Journal of the National Cancer Institute (Print)<sup><img id='00278874_16' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='00278874' /></sup>, v. 104, p. 1280-1292, 2012. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1093/jnci/djs335&issn=00278874&volume=104&issue=&paginaInicial=1280&titulo=Neurokinin-1 Receptor Antagonists for Chemotherapy-Induced Nausea and Vomiting: A Systematic Review&sequencial=16&nomePeriodico=Journal of the National Cancer Institute (Print)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>17. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Messiou, C.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2012</span>
		<img src="images/curriculo/ico_relevante.gif" style='icone-relevancia' />
		<a class="icone-producao icone-doi" href="http://dx.doi.org/10.1148/radiol.12112565" target="_blank"></a>Messiou, C. ; ORTON, M. ; Ang, J. E. ; COLLINS, D. J. ; MORGAN, V. A. ; MEARS, D. ; CASTELLANO, I. ; PAPADATOS-PASTOS, D. ; <b>Brunetto, A.</b> ; Tunariu, N. ; MANN, H. ; TESSIER, J. ; YOUNG, H. ; GHIORGHIU, D. ; MARLEY, S. ; Kaye, S. B. ; DEBONO, J. S. ; Leach, M. O. ; deSouza, N. M. . Advanced Solid Tumors Treated with Cediranib: Comparison of Dynamic Contrast-enhanced MR Imaging and CT as Markers of Vascular Activity. Radiology<sup><img id='00338419_17' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='00338419' /></sup>, v. 265, p. 426-436, 2012. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1148/radiol.12112565&issn=00338419&volume=265&issue=&paginaInicial=426&titulo=Advanced Solid Tumors Treated with Cediranib: Comparison of Dynamic Contrast-enhanced MR Imaging and CT as Markers of Vascular Activity&sequencial=17&nomePeriodico=Radiology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>18. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Abujamra, Ana Lucia</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2012</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1002/pbc.24236" target="_blank"></a><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/8486464868891415" target="_blank">Abujamra, Ana Lucia</a> ; DALL'IGNA, CELSO ; Coradini, Patrícia ; Manica, Denise ; <b>Brunetto, André</b> ; Escosteguy, Juliana Ribas ; Cigana, Luciana Facchini ; Gregianin, Lauro José . The use of high-frequency audiometry increases the diagnosis of asymptomatic hearing loss in pediatric patients treated with cisplatin-based chemotherapy. Pediatric Blood & Cancer<sup><img id='15455009_18' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='15455009' /></sup>, v. na, p. n/a-n/a, 2012. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1002/pbc.24236&issn=15455009&volume=na&issue=&paginaInicial=n/a&titulo=The use of high-frequency audiometry increases the diagnosis of asymptomatic hearing loss in pediatric patients treated with cisplatin-based chemotherapy&sequencial=18&nomePeriodico=Pediatric Blood & Cancer" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>19. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Yap, T. A.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2011</span>
		<img src="images/curriculo/ico_relevante.gif" style='icone-relevancia' />
		<a class="icone-producao icone-doi" href="http://dx.doi.org/10.1200/JCO.2010.31.0367" target="_blank"></a>Yap, T. A. ; Olmos, D. ; <b>BRUNETTO, A. T.</b> ; Tunariu, N. ; Barriuso, J. ; Riisnaes, R. ; Pope, L. ; Clark, J. ; Futreal, A. ; Germuska, M. ; Collins, D. ; deSouza, N. M. ; Leach, M. O. ; Savage, R. E. ; Waghorne, C. ; Chai, F. ; Garmey, E. ; Schwartz, B. ; Kaye, S. B. ; de Bono, J. S. . Phase I Trial of a Selective c-MET Inhibitor ARQ 197 Incorporating Proof of Mechanism Pharmacodynamic Studies. Journal of Clinical Oncology<sup><img id='0732183X_19' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='0732183X' /></sup>, v. 29, p. 1271-1279, 2011. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1200/JCO.2010.31.0367&issn=0732183X&volume=29&issue=&paginaInicial=1271&titulo=Phase I Trial of a Selective c-MET Inhibitor ARQ 197 Incorporating Proof of Mechanism Pharmacodynamic Studies&sequencial=19&nomePeriodico=Journal of Clinical Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>20. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Olmos, D.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2011</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1158/1078-0432.CCR-10-2946" target="_blank"></a>Olmos, D. ; Barker, D. ; Sharma, R. ; <b>BRUNETTO, A. T.</b> ; Yap, T. A. ; Taegtmeyer, A. B. ; Barriuso, J. ; Medani, H. ; Degenhardt, Y. Y. ; Allred, A. J. ; Smith, D. A. ; Murray, S. C. ; Lampkin, T. A. ; Dar, M. M. ; Wilson, R. ; de Bono, J. S. ; Blagden, S. P. . Phase I Study of GSK461364, a Specific and Competitive Polo-like Kinase 1 Inhibitor, in Patients with Advanced Solid Malignancies. Clinical Cancer Research (Print)<sup><img id='10780432_20' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='10780432' /></sup>, v. 17, p. 3420-3430, 2011. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1158/1078-0432.CCR-10-2946&issn=10780432&volume=17&issue=&paginaInicial=3420&titulo=Phase I Study of GSK461364, a Specific and Competitive Polo-like Kinase 1 Inhibitor, in Patients with Advanced Solid Malignancies&sequencial=20&nomePeriodico=Clinical Cancer Research (Print)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>21. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Petrarca, Cristiane Rios</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2011</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1016/j.clbc.2011.03.002" target="_blank"></a>Petrarca, Cristiane Rios ; <b>Brunetto, Andre T.</b> ; Duval, Vinicius ; Brondani, Adriana ; Carvalho, Gisele Pereira ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/1932469223571976" target="_blank">Garicochea, Bernardo</a> . Survivin As a Predictive Biomarker of Complete Pathologic Response to Neoadjuvant Chemotherapy in Patients With Stage II and Stage III Breast Cancer. Clinical Breast Cancer<sup><img id='15268209_21' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='15268209' /></sup>, v. 11, p. 129-134, 2011. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1016/j.clbc.2011.03.002&issn=15268209&volume=11&issue=&paginaInicial=129&titulo=Survivin As a Predictive Biomarker of Complete Pathologic Response to Neoadjuvant Chemotherapy in Patients With Stage II and Stage III Breast Cancer&sequencial=21&nomePeriodico=Clinical Breast Cancer" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>22. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Brunetto, Andre</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2011</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1155/2011/861401" target="_blank"></a><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/8913704029973970" target="_blank">Brunetto, Andre</a></b>; Olmos, David ; Arkenau, Hendrik-Tobias ; Tan, Daniel ; Yap, Timomy ; de Bono, Johann ; Barriuso, Jorge ; Kaye, Stan . Perceptions and Referral Trends into Phase I Oncology Trials: Results of a Clinical Survey. Journal of Oncology<sup><img id='16878450_22' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='16878450' /></sup>, v. 2011, p. 1-6, 2011. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1155/2011/861401&issn=16878450&volume=2011&issue=&paginaInicial=1&titulo=Perceptions and Referral Trends into Phase I Oncology Trials: Results of a Clinical Survey&sequencial=22&nomePeriodico=Journal of Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>23. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Blanco Codesido, Montserrat</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2011</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1159/000330206" target="_blank"></a>Blanco Codesido, Montserrat ; <b>Tesainer Brunetto, Andre</b> ; Frentzas, Sophia ; Moreno Garcia, Victor ; Papadatos-Pastos, Dionysis ; Pedersen, Joanna Vitfell ; Trani, Leonardo ; Puglisi, Martina ; Molife, L. Rhoda ; Banerji, Udai . Outcomes of Patients with Metastatic Melanoma Treated with Molecularly Targeted Agents in Phase I Clinical Trials. Oncology<sup><img id='14230232_23' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='14230232' /></sup>, v. 81, p. 135-140, 2011. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1159/000330206&issn=14230232&volume=81&issue=&paginaInicial=135&titulo=Outcomes of Patients with Metastatic Melanoma Treated with Molecularly Targeted Agents in Phase I Clinical Trials&sequencial=23&nomePeriodico=Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>24. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Brunetto, Andre Tesainer</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2011</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.4155/cli.11.104" target="_blank"></a><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/8913704029973970" target="_blank">Brunetto, Andre Tesainer</a></b>; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/6516219295405539" target="_blank">Roesler, Rafael</a> ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/8486464868891415" target="_blank">Abujamra, Ana Lucia</a> ; de Castro, Claudio Galvão ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/9574856139602553" target="_blank">Schwartsmann, Gilberto</a> ; Brunetto, Algemir Lunardi . The process of drug development in pediatric oncology: a review of basic principals and a look into the future. Future Medicinal Chemistry<sup><img id='20416792_24' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='20416792' /></sup>, v. 1, p. 1237-1249, 2011. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.4155/cli.11.104&issn=20416792&volume=1&issue=&paginaInicial=1237&titulo=The process of drug development in pediatric oncology: a review of basic principals and a look into the future&sequencial=24&nomePeriodico=Future Medicinal Chemistry" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>25. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Moreira Lima Gamboa, M.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2011</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1016/j.farma.2010.10.006" target="_blank"></a>Moreira Lima Gamboa, M. ; <b>Tesainer Brunetto, A.</b> ; Ferreira Dos Santos, M.E. ; Gregianin, L. . The pharmacists role in clinical research. Farmacia Hospitalaria<sup><img id='11306343_25' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='11306343' /></sup>, v. 35, p. 341-342, 2011. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1016/j.farma.2010.10.006&issn=11306343&volume=35&issue=&paginaInicial=341&titulo=The pharmacists role in clinical research&sequencial=25&nomePeriodico=Farmacia Hospitalaria" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>26. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Brunetto, A T</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2010</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1038/sj.bjc.6605812" target="_blank"></a><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/8913704029973970" target="_blank">Brunetto, A T</a></b>; Sarker, D ; Papadatos-Pastos, D ; Fehrmann, R ; Kaye, S B ; Johnston, S ; Allen, M ; De Bono, J S ; Swanton, C . A retrospective analysis of clinical outcome of patients with chemo-refractory metastatic breast cancer treated in a single institution phase I unit. British Journal of Cancer<sup><img id='00070920_26' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='00070920' /></sup>, v. 103, p. 607-612, 2010. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1038/sj.bjc.6605812&issn=00070920&volume=103&issue=&paginaInicial=607&titulo=A retrospective analysis of clinical outcome of patients with chemo-refractory metastatic breast cancer treated in a single institution phase I unit&sequencial=26&nomePeriodico=British Journal of Cancer" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>27. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Brunetto, Andre T.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2010</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1097/JTO.0b013e3181eba7f9" target="_blank"></a><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/8913704029973970" target="_blank">Brunetto, Andre T.</a></b>; Carden, Craig P. ; Myerson, James ; Faria, Ana Luisa ; Ashley, Sue ; Popat, Sanjay ; O?Brien, Mary E. R. . Modest Reductions in Dose Intensity and Drug-Induced Neutropenia have No Major Impact on Survival of Patients with Non-small Cell Lung Cancer Treated with Platinum-Doublet Chemotherapy. Journal of Thoracic Oncology<sup><img id='15560864_27' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='15560864' /></sup>, v. 5, p. 1397-1403, 2010. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1097/JTO.0b013e3181eba7f9&issn=15560864&volume=5&issue=&paginaInicial=1397&titulo=Modest Reductions in Dose Intensity and Drug-Induced Neutropenia have No Major Impact on Survival of Patients with Non-small Cell Lung Cancer Treated with Platinum-Doublet Chemotherapy&sequencial=27&nomePeriodico=Journal of Thoracic Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>28. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>BRUNETTO, A. T.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2010</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.2217/fon.10.92" target="_blank"></a><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/8913704029973970" target="_blank">BRUNETTO, A. T.</a></b>; Kristeleit, Rebecca S ; de Bono, Johann S . Early oncology clinical trial design in the era of molecular-targeted agents. Future Oncology<sup><img id='14796694_28' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='14796694' /></sup>, v. 6, p. 1339-1352, 2010. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.2217/fon.10.92&issn=14796694&volume=6&issue=&paginaInicial=1339&titulo=Early oncology clinical trial design in the era of molecular-targeted agents&sequencial=28&nomePeriodico=Future Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>29. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Brunetto, Andre T.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2010</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1016/j.ejca.2010.06.123" target="_blank"></a><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/8913704029973970" target="_blank">Brunetto, Andre T.</a></b>; Ang, Joo Ern ; Olmos, David ; Tan, Daniel ; Barriuso, Jorge ; Arkenau, Hendrik-Tobias ; Yap, Timothy A. ; Molife, L. Rhoda ; Banerji, Udai ; de Bono, Johann . A study of the pattern of hospital admissions in a specialist Phase I oncology trials unit: Unplanned admissions as an early indicator of patient attrition?. European Journal of Cancer<sup><img id='09598049_29' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='09598049' /></sup>, v. 46, p. 2739-2745, 2010. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1016/j.ejca.2010.06.123&issn=09598049&volume=46&issue=&paginaInicial=2739&titulo=A study of the pattern of hospital admissions in a specialist Phase I oncology trials unit: Unplanned admissions as an early indicator of patient attrition?&sequencial=29&nomePeriodico=European Journal of Cancer" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>30. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Roesler, Rafael</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2010</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1586/era.10.167" target="_blank"></a><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/6516219295405539" target="_blank">Roesler, Rafael</a> ; <b>Brunetto, André T</b> ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/8486464868891415" target="_blank">Abujamra, Ana Lucia</a> ; de Farias, Caroline Brunetto ; Brunetto, Algemir Lunardi ; <a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/9574856139602553" target="_blank">Schwartsmann, Gilberto</a> . Current and emerging molecular targets in glioma. Expert Review of Anticancer Therapy<sup><img id='14737140_30' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='14737140' /></sup>, v. 10, p. 1735-1751, 2010. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1586/era.10.167&issn=14737140&volume=10&issue=&paginaInicial=1735&titulo=Current and emerging molecular targets in glioma&sequencial=30&nomePeriodico=Expert Review of Anticancer Therapy" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>31. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>BRUNETTO, A. T.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2010</span><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/8913704029973970" target="_blank">BRUNETTO, A. T.</a></b>. O desenvolvimento de novas drogas contra o câncer- revisão e perspectivas futuras. Prática Hospitalar (Impresso)<sup><img id='16770447_31' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='16770447' /></sup>, v. 71, p. 8-14, 2010. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=16770447&volume=71&issue=&paginaInicial=8&titulo=O desenvolvimento de novas drogas contra o câncer- revisão e perspectivas futuras&sequencial=31&nomePeriodico=Prática Hospitalar (Impresso)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>32. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Arkenau, Hendrik-Tobias</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2009</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1159/000195884" target="_blank"></a>Arkenau, Hendrik-Tobias ; <b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/8913704029973970" target="_blank">BRUNETTO, A. T.</a></b> ; Barriuso, Jorge ; Olmos, David ; Eaton, David ; de Bono, Johann ; Judson, Ian ; Kaye, Stan . Clinical Benefit of New Targeted Agents in Phase I Trials in Patients with Advanced Colorectal Cancer. Oncology<sup><img id='14230232_32' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='14230232' /></sup>, v. 76, p. 151-156, 2009. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1159/000195884&issn=14230232&volume=76&issue=&paginaInicial=151&titulo=Clinical Benefit of New Targeted Agents in Phase I Trials in Patients with Advanced Colorectal Cancer&sequencial=32&nomePeriodico=Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>33. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Yap, Timothy A</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2008</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1517/13543780802533401" target="_blank"></a>Yap, Timothy A ; <b>BRUNETTO, A. T.</b> ; Pandha, Hardev ; Harrington, Kevin ; de Bono, Johann S . Reovirus therapy in cancer: has the orphan virus found a home?. Expert Opinion on Investigational Drugs<sup><img id='13543784_33' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='13543784' /></sup>, v. 17, p. 1925-1935, 2008. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1517/13543780802533401&issn=13543784&volume=17&issue=&paginaInicial=1925&titulo=Reovirus therapy in cancer: has the orphan virus found a home?&sequencial=33&nomePeriodico=Expert Opinion on Investigational Drugs" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
</div>
<div class="cita-artigos">
<b><a name="CapitulosLivrosPublicados"></a>Capítulos de livros publicados</b>
</div>
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1007/978-1-4614-3369-9_35" target="_blank"></a><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/9574856139602553" target="_blank">Schwartsmann, Gilberto</a> ; <b>Brunetto, Andre T.</b> . Evolution of Truth-Telling Practices in Brazil and South America. New Challenges in Communication with Cancer Patients. 1ed.: Springer US, 2013, v. , p. 419-428. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">LEAL, F. ; <b>Brunetto, Andre Tesainer</b> ; MARTELETE, M. ; Schwartsmann, G. . Cancer. In: Bruce B. Duncan. (Org.). Medicina Ambulatorial: Condutas de Atenção Primária Baseadas em Evidências. 4ed.São Paulo: ARTmed, 2013, v. 1, p. 1040-1046. </div>
</div>
<br class="clear">
<div class="cita-artigos">
<b><a name="TrabalhosPublicadosAnaisCongresso"></a>Resumos publicados em anais de congressos</b>
</div>
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">GENNARO,D ; <b>BRUNETTO, A. T.</b> ; et al. . Phase I dose-finding study of golvatinib (E7050), a c-Met and Eph receptor targeted multi-kinase inhibitor, administered orally QD to patients with advanced solid tumors. In: American Society of Clinical Oncology (ASCO), 2012, Chicago. Journal of Clinical Oncology, 2012. v. 30. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Ang, J.E. ; GARCIA, V. ; <b>BRUNETTO, A. T.</b> ; Papadatos-Pastos, D ; Arkenau, Hendrik-Tobias ; Blanco-Codesido, M. ; et al. . Utility of novel dynamic clinical indices in patients (pts) enrolled in a phase I (Ph I) oncology trial as markers of prognosis and treatment benefit.. In: ASCO, 2011, Boston. ASCO MEETING ABSTRACTS Jun 9, 2011:2555, 2011. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>3. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Blanco-Codesido, M. ; <b>BRUNETTO, A. T.</b> ; Frentzas,S. ; GARCIA, V. ; Papadatos-Pastos, D ; et al. . Clinical outcome of patients with metastasic melanoma undergoing phase I clinical trials. In: ASCO, 2011, Boston. ASCO MEETING ABSTRACTS Jun 9, 2011:8564. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>4. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">CASSIER, P. ; GARCIA, V. ; Rocca, G. ; Olmos D. ; <b>BRUNETTO, A. T.</b> ; et al. . Dose-response relationship in phase I clinical trials: A European Drug Development Network (EDDN) collaboration study. In: ASCO, 2011, Boston. ASCO MEETING ABSTRACTS Jun 9, 2011:3084, 2011. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>5. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Mattei, Jane ; Kat, Y. ; Roesler, R. ; <b>BRUNETTO, A. T.</b> ; et al. . Gastrin-releasing peptide receptor expression in Brazilian and Japanese patients with lung cancer and normal lung tissue samples from healthy individuals.. In: ASCO, 2011, Boston. ASCO MEETING ABSTRACTS Jun 9, 2011:10588, 2011. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>6. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/8913704029973970" target="_blank">BRUNETTO, A. T.</a></b>; Borges, G. ; Araújo, M.C. ; Filipe, G. ; Ribeiro, A. . Prognosis of patients with breast cancer (BC) in southern Brazil based on immunohistochemistry (IHC) and TNM staging.. In: ASCO, 2011, Boston. ASCO MEETING ABSTRACTS Jun 9, 2011:e12013, 2011. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>7. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Papadatos-Pastos, D ; Blanco-Codesido, M. ; Carden, Craig P. ; Fehrmann, R ; Trani, L. ; Molife, R. ; <b>BRUNETTO, A. T.</b> ; Sandhu, S ; Massard, C. ; Banerji, Udai . Should patients with malignant intracranial space occupying lesions (M-ICSOLs) be excluded from phase I trials? The Royal Marsden Hospital Drug Development Unit experience.. In: ASCO, 2010, Boston. Journal of Clinical Oncology, 2010. v. 28. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>8. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Alam, S. ; Fehrmann, R ; Olmos D. ; Shah, K. ; Puglisi, M ; <b>BRUNETTO, A. T.</b> ; Postel-Viney, S. ; Baird, R. ; Molife, R. . Defining the risk of toxicity in phase I oncology trials of novel molecularly targeted agents: A single-center experience.. In: ASCO, 2010, Boston. Journal of Clinical Oncology, 2010. v. 28. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>9. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1093/annonc/mdq519" target="_blank"></a>Blanco-Codesido, M. ; <b>BRUNETTO, A. T.</b> ; Frentzas,S. . Clinical and preclinical development of 4SC-201, a new oral histone deacetylase (HDAC) inhibitor. In: Joint ECCO 15 ? 34th ESMO Multidisciplinary Congress, 2010, Milan. Annals of Oncology, 2010. v. 21. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>10. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1016/S1359-6349(10)72112-1" target="_blank"></a>Ang, J.E. ; Clarkson-Jones, J.A. ; Swaisland, H. ; <b>Brunetto, A.T.</b> ; Lal, R. ; Farnsworth, A.P. ; Molife, L.R. ; Kaye, S.B. ; Carmichael, J. ; de Bono, J.S. . 405 A mass balance study to investigate the metabolism, excretion and pharmacokinetics of [14C]-olaparib (AZD2281) in patients with advanced solid tumours refractory to standard treatments. In: 22nd EORTC ? NCI?AACR Symposium on Molecular Targets and Cancer Therapeutics Programme and Abstract Book, 2010. European Journal of Cancer Supplements, 2010. v. 8. p. 128. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>11. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/8913704029973970" target="_blank">BRUNETTO, A. T.</a></b>; Ang, J.E. ; Lal, R. ; Olmos D. ; Frentzas,S. ; Mais,A ; Hauns,B. ; Mollenhauer, M. ; Lahu,G. ; de Bono, Johann S . A first-in-human phase I study of 4SC-201, an oral histone deacetylase (HDAC) inhibitor, in patients with advanced solid tumors.. In: ASCO annual meeting, 2009, Orlando. Journal of Clinical Oncology, 2009. v. 27. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>12. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Olmos D. ; Alrred,R. ; Sharma, R ; <b>BRUNETTO, A. T.</b> ; Smith, D. ; Murray, S. ; Barker,D. ; Taegtmeyer,A. ; De Bono, J S ; Blagden,S. . Phase I first-in-human study of the polo-like kinase-1 selective inhibitor, GSK461364, in patients with advanced solid tumors. In: ASCO annual meeting, 2009, Orlando. Journal of Clinical Oncology, 2009. v. 27. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>13. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Tan, Daniel ; <b>BRUNETTO, A. T.</b> ; Ang, J.E. ; Olmos D. ; Barriuso, Jorge ; Frentzas,S. ; Arkenau, Hendrik-Tobias ; Yap, Timothy A ; de Bono J.S. . Unplanned hospital admissions as an early surrogate indicator of patient (pt) attrition in phase I trials.. In: ASCO annual meeting, 2009, Orlando. Journal of Clinical Oncology. v. 27. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>14. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Tolcher, A. ; Yap, Timothy A ; Fearen, A. ; Taylor,C. ; <b>BRUNETTO, A. T.</b> ; Beeram, M. ; Yan,L. ; de Bono J.S. . A phase I study of MK-2206, an oral potent allosteric Akt inhibitor (Akti), in patients (pts) with advanced solid tumor (ST).. In: ASCO annual meeting, 2009, Orlando. Journal of Clinical Oncology, 2010. v. 27. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>15. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1016/S1359-6349(09)70470-7" target="_blank"></a><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/8913704029973970" target="_blank">BRUNETTO, A. T.</a></b>; Tan, D.S.W. ; Olmos, D. ; YAP, T. ; Frentzas, S. ; Sandhu, S. ; Denholm, K. ; Ayite, B. ; de Bono, J. ; Kaye, S. . 1258 Changing perceptions of oncologists referring advanced colorectal (ACRC) patients (pts) to phase 1 trials: an evidence based approach. In: ECCO 15 ? 34th ESMO Multidisciplinary Congress, 2009, Berlin. European Journal of Cancer. v. 7. p. 138-138. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>16. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">YAP, T. ; Lolkema, M. ; Tanariu, N. ; Tan, D.S.W. ; <b>BRUNETTO, A. T.</b> ; Germuska,M. ; Garmey,E. ; Souza, N. ; de Bono J.S. . Pharmacokinetic and pharmacodynamic Phase I trial of ARQ 197 incorporating dynamic contrast-enhanced (DCE) and diffusion weighted (DW) magnetic resonance imaging (MRI) studies investigating the antiangiogenic and antitumor activity of selective cMet inhi. In: Joint ECCO 15 - 34TH ESMO, 2009, Berlin. European Journal of Cancer, 2009. v. 7. p. 121-121. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>17. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Olmos D. ; <b>BRUNETTO, A. T.</b> ; Ang, J.E. ; Tan, D.S.W. ; Sandhu, S ; Kristeleit, R. ; Forster, M. ; Molife, R. ; Kaye S.B. . Retrospective analysis of unplanned hospital admissions: an early surrogate indicator of patient (pt) attrition in phase-I trials. In: Joint ECCO 15 - 34TH ESMO, 2009, Berlin. European Journal of Cancer, 2009. v. 7. p. 137-137. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>18. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1093/annonc/mdp219" target="_blank"></a>Tan, D.S.W. ; <b>BRUNETTO, A. T.</b> ; YAP, T. ; Frentzas,S. ; Kaye S.B. . oral presentation gynaecological cancers. In: ECCLU - Educational Cancer Convention, 2009, Lugano. Annals of Oncology. v. 22. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>19. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1093/annonc/mdp220" target="_blank"></a><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/8913704029973970" target="_blank">BRUNETTO, A. T.</a></b>; Tan, D.S.W. ; YAP, T. ; Olmos D. ; Kaye S.B. . poster presentation gynaecological cancers. In: ECCLU - Educational Cancer Convention, 2009, Lugano. Annals of Oncology, 2009. v. 20. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>20. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1158/1535-7163.TARG-09-B135" target="_blank"></a>Yap, Timothy A ; <b>BRUNETTO, A. T.</b> . First-in-man, first-in-class phase I study of two schedules of MK-2206, a novel oral Akt inhibitor, in patients (pts) with advanced solid tumors, including ovarian and castration resistant prostate cancer (CRPC). In: Molecular Cancer Therapeutics 8, 2009, Boston. Molecular Cancer Therapeutics 8 (Meeting Abstract Supplement). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>21. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1016/S1359-6349(09)70467-7" target="_blank"></a>de Bono, J. ; <b>Brunetto, A.T.</b> ; Kristeleit, R. ; Mais, A. ; Hauns, B. ; Hentsch, B. . 1255 Clinical and preclinical development of 4SC-201, a new oral histone deacetylase (HDAC) inhibitor. In: ESMO, 2009, Berlin. European Journal of Cancer Supplements, 2009. v. 7. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>22. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1016/S0169-5002(08)70064-3" target="_blank"></a><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/8913704029973970" target="_blank">BRUNETTO, A. T.</a></b>; CARDEN, C ; ASHLEY, S ; BAIRD, R ; MYERSON, J ; KRISTELEIT, R ; MONTES, A ; POPAT, S ; OBRIEN, M . Dose intensity in advanced non-small cell lung cancer. In: Bristish Thoracic Oncology Group (BTOG) meeting, 2008, Dublin. Lung Cancer. v. 60. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>23. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1016/S1359-6349(08)72354-1" target="_blank"></a><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/8913704029973970" target="_blank">BRUNETTO, A. T.</a></b>; KRARUPHANSEN, A ; NIELSEN, O ; NORMAN, A ; SAFWAT, A ; TJORNELUND, J ; JUDSON, I . 420 POSTER A phase I clinical trial of belinostat (PXD101) in combination with doxorubicin (BelDox) in advanced solid tumours, including soft tissue sarcomas (STS). In: 20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics Programme, 2008, Geneva. European Journal of Cancer. v. 6. p. 132-132. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>24. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1093/annonc/mdn508" target="_blank"></a>Barriuso, Jorge ; Arkenau, Hendrik-Tobias ; Olmos D. ; Ang, J.E. ; Frentzas,S. ; <b>BRUNETTO, A. T.</b> ; Judson, I. ; de Bono J.S. ; Kaye S.B. . developmental therapeutics. In: 33rd ESMO Congress, 2008, Stockholm. Annals of Oncology, 2008. v. 19. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>25. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1093/annonc/mdn504" target="_blank"></a>PAPADOPOULOS, P. ; <b>BRUNETTO, A. T.</b> ; Ashley, Sue ; Allen, M ; Smith, I. ; O?Brien, Mary E. R. . breast cancer, advanced. In: 33rd ESMO Congress, 2008, Stockholm. Annals of Oncology, 2008. v. 19. </div>
</div>
<br class="clear">
<div class="cita-artigos">
<b><a name="ApresentacoesTrabalho"></a>Apresentações de Trabalho</b>
</div>
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Ang, Joo Ern ; Co-autor ; <b>Brunetto, A.T.</b> . Utility of novel dynamic clinical indices in patients (pts) enrolled in a phase I (Ph I) oncology trial as markers of prognosis and treatment benefit. 2011. (Apresentação de Trabalho/Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Blanco-Codesido, M. ; Co-autor ; <b>Brunetto, A.T.</b> . Clinical outcome of patients with metastasic melanoma undergoing phase I clinical trials.. 2011. (Apresentação de Trabalho/Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>3. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">CASSIER, P. ; Co-autor ; <b>Brunetto, A.T.</b> . Dose-response relationship in phase I clinical trials: A European Drug Development Network (EDDN) collaboration study.. 2011. (Apresentação de Trabalho/Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>4. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Mattei, Jane ; Co-autor ; <b>Brunetto, A.T.</b> . Gastrin-releasing peptide receptor expression in Brazilian and Japanese patients with lung cancer and normal lung tissue samples from healthy individuals. 2011. (Apresentação de Trabalho/Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>5. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Alam, S. ; Co-autor ; <b>BRUNETTO, A. T.</b> . Defining the risk of toxicity in phase I oncology trials of novel molecularly targeted agents: A single-center experience. 2010. (Apresentação de Trabalho/Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>6. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Papadatos-Pastos, D ; Co-autor ; <b>BRUNETTO, A. T.</b> . Should patients with malignant intracranial space occupying lesions (M-ICSOLs) be excluded from phase I trials? The Royal Marsden Hospital Drug Development Unit experience.. 2010. (Apresentação de Trabalho/Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>7. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Tolcher, A. ; Co-autor ; <b>BRUNETTO, A. T.</b> . A phase I study of MK-2206, an oral potent allosteric Akt inhibitor (Akti), in patients (pts) with advanced solid tumor (ST). 2009. (Apresentação de Trabalho/Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>8. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/8913704029973970" target="_blank">BRUNETTO, A. T.</a></b>. A first in human Phase I study of 4SC-201, an oral histone deacetylase (HDAC) inhibitor, in patients with advanced solid tumors.. 2009. (Apresentação de Trabalho/Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>9. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/8913704029973970" target="_blank">BRUNETTO, A. T.</a></b>. Complications of Anti-angiogenic therapy. 2009. (Apresentação de Trabalho/Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>10. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Tan, D.S.W. ; Co-autor ; <b>BRUNETTO, A. T.</b> . BRCA1 positive ovarian cancer: A predisposition to therapeutic selectivity. 2009. (Apresentação de Trabalho/Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>11. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Tan, D.S.W. ; Co-autor ; <b>BRUNETTO, A. T.</b> . Unplanned hospital admissions as an early surrogate indicator of patient (pt) attrition in Phase I trials. 2009. (Apresentação de Trabalho/Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>12. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Olmos D. ; Co-autor ; <b>BRUNETTO, A. T.</b> . Phase 1 first in human study of polo-like kinase selective inhibitor, GSK461364, in patients with advanced solid tumors. 2009. (Apresentação de Trabalho/Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>13. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Lolkema, M. ; Co-autor ; <b>BRUNETTO, A. T.</b> . Final results of Pharmacokinetic (PK) and pharmacodynamic (PD) Phase I trial of ARQ197 incorporating dynamic contrast-enhanced (DCE) and diffusion weighted (DW) magnetic resonance imaging (MRI) studies investigating the antiangiogenic activity of selective c-Met inhibition.. 2009. (Apresentação de Trabalho/Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>14. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/8913704029973970" target="_blank">BRUNETTO, A. T.</a></b>. Phase 1 treatment in advanced colorectal cancer (ACRC).. 2009. (Apresentação de Trabalho/Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>15. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">YAP, T. ; Co-autor ; <b>BRUNETTO, A. T.</b> . First in man, first in class, phase I study of MK-2206, an oral potent allosteric Akt inhibitor, in patients with advanced solid tumours. 2009. (Apresentação de Trabalho/Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>16. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">de Bono J.S. ; Co-autor ; <b>BRUNETTO, A. T.</b> . Clinical and preclinical development of 4SC-201, a new oral histone deacetylase (HDAC) inhibitor. 2009. (Apresentação de Trabalho/Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>17. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">YAP, T. ; Co-autor ; <b>BRUNETTO, A. T.</b> . Pharmacokinetic (PK) and pharmacodynamic (PD) Phase I trial of ARQ197 incorporating dynamic contrast-enhanced (DCE) and diffusion weighted (DW) magnetic resonance imaging (MRI) studies investigating the antiangiogenic activity of selective c-Met inhibition.. 2009. (Apresentação de Trabalho/Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>18. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">De Bono, J S ; Co-autor ; <b>BRUNETTO, A. T.</b> . Clinical and preclinical development of 4SC-201, a new oral histone deacetylase (HDAC) inhibitor.. 2009. (Apresentação de Trabalho/Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>19. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/8913704029973970" target="_blank">BRUNETTO, A. T.</a></b>. Changing perceptions of oncologists referring advanced colorectal (ACRC) patients (pts) to phase 1 trials: an evidence based approach.. 2009. (Apresentação de Trabalho/Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>20. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/8913704029973970" target="_blank">BRUNETTO, A. T.</a></b>. A first in human Phase I study of JNJ26481585, a novel oral histone deacetylase inhibitor (HDACi), in patients with advanced solid tumours: early evidence of anti-tumor activity. 2009. (Apresentação de Trabalho/Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>21. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Frentzas,S. ; Co-autor ; <b>BRUNETTO, A. T.</b> . A study of melanoma patients in Phase I clinical trials: looking beyond the established. 2009. (Apresentação de Trabalho/Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>22. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Sarker, D ; Co-autor ; <b>BRUNETTO, A. T.</b> . Safety and feasibility of serial tumour biopsies in phase I clinical trials: the Royal Marsden Hospital Drug Development Unit experience. 2009. (Apresentação de Trabalho/Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>23. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Tan, D.S.W. ; Co-autor ; <b>BRUNETTO, A. T.</b> . A phase-I study of the combination of intravenous reovirus (REOLYSIN ) and gemcitabine in patients with advanced cancer.. 2009. (Apresentação de Trabalho/Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>24. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Kristeleit, R. ; Co-autor ; <b>BRUNETTO, A. T.</b> . A first-in-man, dose-escalating Phase I study of 4SC-201, a new oral histone deacetylase (HDAC) inhibitor in patients with advanced solid tumours. 2009. (Apresentação de Trabalho/Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>25. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Sandhu, S. ; Co-autor ; <b>BRUNETTO, A. T.</b> . Pharmacokinetic and pharmacodynamic phase I trial of ARQ197 incorporating dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) studies investigating the antiangiogenic activity of selective c-Met inhibition. 2009. (Apresentação de Trabalho/Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>26. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Olmos D. ; Co-autor ; <b>BRUNETTO, A. T.</b> . Factores Prognosticos para la Supervivencia en Pacientes Incluidos en Ensayos Clinicos Fase-I.. 2009. (Apresentação de Trabalho/Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>27. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Henning, S.W. ; Co-autor ; <b>BRUNETTO, A. T.</b> . Preclinical and clinical development of resminostat, a new oral histone deacetylase (HDAC) inhibitor. 2009. (Apresentação de Trabalho/Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>28. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Olmos D. ; Co-autor ; <b>BRUNETTO, A. T.</b> . Retrospective analysis of unplanned hospital admissions: an early surrogate indicator of patient (pt) attrition in phase-I trials. 2009. (Apresentação de Trabalho/Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>29. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/8913704029973970" target="_blank">BRUNETTO, A. T.</a></b>. Dose-intensity in non-small cell lung cancer. 2008. (Apresentação de Trabalho/Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>30. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">PAPADOPOULOS, P. ; Co-autor ; <b>BRUNETTO, A. T.</b> . The use of trastuzumab in metastatic breast cancer beyond disease progression. 2008. (Apresentação de Trabalho/Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>31. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Barriuso, Jorge ; Co-autor ; <b>BRUNETTO, A. T.</b> . Prospective validation of a prognostic score for patients treated in phase I trials.. 2008. (Apresentação de Trabalho/Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>32. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/8913704029973970" target="_blank">BRUNETTO, A. T.</a></b>. The Royal Marsden Hospital (RMH) prognostic score for phase I studies. 2008. (Apresentação de Trabalho/Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>33. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Ang, J.E. ; Co-autor ; <b>BRUNETTO, A. T.</b> . First-in-man phase I trial of BYK408740, an oral HDAC inhibitor, in patients with advanced malignancies. 2008. (Apresentação de Trabalho/Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>34. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/8913704029973970" target="_blank">BRUNETTO, A. T.</a></b>. A phase I clinical trial of Belinostat (PXD101) in combination with Doxorubicin (BelDox) in advanced solid tumours, including soft tissue sarcomas (STS).. 2008. (Apresentação de Trabalho/Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>35. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Rech, A. ; Co-autor ; <b>BRUNETTO, A. T.</b> . Hodgkin Lymphoma in the Department of Pediatric Oncology. 2004. (Apresentação de Trabalho/Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>36. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Rech, A. ; Co-autor ; <b>BRUNETTO, A. T.</b> . Epidemiology of Non-hodgkin Lymphoma in the Department of Pediatric Oncology. 2001. (Apresentação de Trabalho/Congresso). </div>
</div>
<br class="clear">
<div class="cita-artigos">
<b><a name="OutrasProducoesBibliograficas"></a>Outras produções bibliográficas</b>
</div>
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/8913704029973970" target="_blank">BRUNETTO, A. T.</a></b>; BRUNETTO, L. ; Garicochea, B. . Tumor Markers in Clinical Practice.
							Porto Alegre:
									EdiPUCRS,  2002 (Acta Medica - capitulo de livro). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b><a class="tooltip" title="Clique para visualizar o currículo" href="http://lattes.cnpq.br/8913704029973970" target="_blank">BRUNETTO, A. T.</a></b>; MARIANTE, A. ; Garicochea, B. . Febrile Neutropenia.
							Porto Alegre:
									EdiPUCRS,  2002 (Manual de Ùrgências Médicas- Faculdade de Medicina e Hospital São Lucas). </div>
</div>
<br class="clear">
</div><br class="clear" /></div><br class="clear" /><div class="title-wrapper">
<a name="Eventos">
<h1>Eventos</h1>
</a>
<hr class="separator">
<div class="layout-cell layout-cell-12 data-cell">
<div class="layout-cell layout-cell-12 data-cell">
<a name="ParticipacaoEventos"></a><br class="clear" /><div class="inst_back">
<b>Participação em eventos, congressos, exposições e feiras</b>
</div>
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Prostate Cancer forum. 2016. (Oficina). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Best of ASCO 2014. Participou com Chairman de sessão sobre Tumores geniturinários. 2014. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>3. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Conference on Lung Cancer.Coordenador sessão oncologia.
							2014. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>4. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">I Fórum de Coloproctologia do HED.O que muda em relação ao tratamento oncológico com a avaliação K-ras e BRAF?.
							2014. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>5. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Best of ASCO 2013. Palestrante câncer de prostata. 2013. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>6. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Preceptorships in oncology. 2012. (Oficina). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>7. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">37 SAEF.Visão Multidisciplinar Farmacêutica no Câncer.
							2011. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>8. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">37 Semana academica estudos farmaceuticos (SAEF).Visão Multidisciplinar farmaceutica do Câncer- diagnóstico.
							2011. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>9. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">American Society of Clinical Oncology (ASCO). 2011. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>10. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Highlights em Câncer de Próstata - CliniOnco. 2011. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>11. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">SICAD - Simpósio Internacional de Câncer do Aparelho Digestivo.Neoplasia Localizada de Cólon e Reto: Novas perspectivas.
							2011. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>12. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Best of American Society of Clinical Oncology (ASCO). Tumores do Sistema Nervoso Central. 2010. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>13. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Congresso Franco Brasileiro de Oncologia. Terapia Aduvante em Cancer Coloratal com cetuximab. 2010. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>14. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Palestrante no evento anual da liga de Neurologia.Manifestações Neurológicas de Doenças Sisêmicas. 2010. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>15. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">American Society of Clinical Oncology (ASCO) Annual Meeting. A first in human Phase I study of 4SC-201, an oral histone deacetylase (HDAC) inhibitor, in patients with advanced solid tumors. 2009. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>16. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Curso Advanced Life Support (ALS). 2009. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>17. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">ECCLU ? Educational Cancer Convention Lugano. Complications of anti-angiogenic therapy.. 2009. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>18. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">European Society of Clinical Oncology (ESMO) Annual Meeting. Changing perceptions of oncologists referring advanced colorectal (ACRC) patients (pts) to phase 1 trials: an evidence based approach. 2009. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>19. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Institute of Cancer Research (ICR) Centenary Conference. Phase 1 treatment in advanced colorectal cancer (ACRC).. 2009. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>20. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">National Cancer Research Institute (NCRI) Annual Conference. A first in human Phase I study of JNJ26481585, a novel oral histone deacetylase inhibitor (HDACi), in patients with advanced solid tumours: early evidence of anti-tumor activity.. 2009. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>21. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Best of American Society of Clinical Oncology (ASCO). Highlights em Sarcoma e Melanoma. 2008. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>22. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Curso de "Cardiopulmonary Resuscitation and Basic life Support. 2008. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>23. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics. A phase I clinical trial of Belinostat (PXD101) in combination with Doxorubicin (BelDox) in advanced solid tumours, including soft tissue sarcomas (STS). 2008. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>24. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">National Cancer Research Institute (NCRI) Annual Conference. The Royal Marsden Hospital (RMH) prognostic score for phase I studies.. 2008. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>25. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Curso de Good Clinical Practice (GCP). 2006. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>26. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Curso dúvidas Comuns na Prática Clínica - PUCRS. 2002. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>27. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Curso Tópicos em Epidemiologia - AMRIGS. 2002. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>28. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Curso Tópicos em Medicina Intensiva - AMRIGS. 2002. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>29. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Curso Tópicos em Medicina Interna I. 2002. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>30. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">5 Congressso sobre Tranplante de Medula Óssea e Hemopatias Malignas. 2001. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>31. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Curso de Extensão Universitária A Morte e o Morrer - PUCRS. 2001. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>32. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Curso de Urgencia em Radiologia - PUCRS. 2001. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>33. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">II Curso de Urgencias em Gatroenterologia- PUCRS. 2001. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>34. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Workshop em Embolia Pulmonar - PUCRS. 2001. (Oficina). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>35. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">XII Congresso Brasileiro de Cirurgia Torácica. 2001. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>36. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">17 Congresso da Associação Médica do Rio Grande do Sul. 2000. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>37. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Curso de Extensão em tópicos de Hematologia- Fundação Médica. 2000. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>38. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">II Congresso Gaúcho de Clinica Medica. 1999. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>39. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">VI Jornada de Pneumologia - PUCRS. 1999. (Oficina). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>40. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">XXIX Encontro científico dos estudantes de Medicina (ECEM).
							1999. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>41. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Curso de Doenças Frequentes, Diagnóstico e Conduta - HCPA. 1998. (Outra). 
					</div>
</div>
<br class="clear">
</div>
</div><br class="clear" /></div><br class="clear" /><br class="clear" /><div class="rodape-cv">P&aacute;gina gerada pelo Sistema Curr&iacute;culo Lattes em 19/09/2019 &agrave;s 23:34:26</div><br class="clear" /><div class="control-bar-wrapper"><a href="download.do?metodo=apresentar&amp;idcnpq=8913704029973970" target="_blank" class="button"><span class="mini-ico mini-ico-down"></span>Baixar Currículo</a><a class="button" href="javascript:window.print()"><span class="mini-ico mini-ico-list"></span>Imprimir Curr&iacute;culo</a>
</div><br class="clear" /></div>
</div>
</div>
</div>
</div>
<div class="to-top-bar" id="toTop">
<a href="javascript:void(0)" class="topo-width center">
<div class="id-orgao">
<span>CNPq</span> | Uma ag&ecirc;ncia do Minist&eacute;rio da Ci&ecirc;ncia, Tecnologia e Inova&ccedil;&atilde;o</div>
</a>
</div>
</BODY>
</HTML>
